Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Three Biotechs Hitting New 52-Week Highs
Seeking Alpha
Wednesday, September 24, 2008 - 9:25am
tags:
Forest Labs See Generic Threat
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 9:22am
tags:
Sanofi Cut to `Underperform' at Credit Suisse; Novartis Raised
Bloomberg
Wednesday, September 24, 2008 - 9:22am
tags:
Bristol Vs. ImClone Heats Up As Icahn Gets Nastier
CNBC
Wednesday, September 24, 2008 - 9:15am
tags:
Pfizer Moves Into Stem Cell Research
WSJ Online
Wednesday, September 24, 2008 - 8:59am
tags:
AstraZeneca says U.S. court denies Teva motion
Marketwatch
Wednesday, September 24, 2008 - 8:58am
tags:
Teva and Kowa to create Japanese generic maker
Yahoo/AP
Wednesday, September 24, 2008 - 8:57am
tags:
Allergan's Wrinkles Need Smoothing
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:32am
tags:
Isis Pharma Our Top Biotech
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:10am
tags:
MannKind shares gain ground on expectations for developing inhaled insulin product
Yahoo/AP
Wednesday, September 24, 2008 - 7:09am
tags:
Lone Bristol-Myers representative on ImClone board resigns as takeover effort turns hostile
Yahoo/AP
Wednesday, September 24, 2008 - 7:09am
tags:
Icahn calls new Bristol bid for ImClone "absurd"
Reuters
Wednesday, September 24, 2008 - 7:08am
tags:
A Tale of Three Pharmaceuticals: Abbott Labs, Pfizer and Eli Lilly & Co.
Seeking Alpha
Wednesday, September 24, 2008 - 7:07am
tags:
Biotech Names With Big Potential
Seeking Alpha
Wednesday, September 24, 2008 - 7:06am
tags:
Schering-Plough Now Must Cut Costs
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:06am
tags:
Sanofi-Aventis gets FDA approval for pediatric use of allergy nasal spray
Yahoo/AP
Wednesday, September 24, 2008 - 7:05am
tags:
FDA Transparency Raises Volatility for Drug Company Shares
WSJ Online
Wednesday, September 24, 2008 - 7:05am
tags:
AstraZeneca Says Teva Denied Motion on Pulmicort
Bloomberg
Wednesday, September 24, 2008 - 7:04am
tags:
Daiichi Awaits India Approval for Ranbaxy After Tender Offer
Bloomberg
Wednesday, September 24, 2008 - 7:03am
tags:
Osiris Completes Enrollment of Stem Cell Trial to Treat Pulmonary Disease
Yahoo
Tuesday, September 23, 2008 - 12:38pm
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.